A screen for microRNAs involved in the cisplatin resistance in bladder cancer

被引：0
|
作者：
Shindo, Tetsuya [1 ]
Nishiyama, Naotaka [1 ]
Niinuma, Takeshi [2 ]
Maruyama, Reo [1 ]
Kitajima, Hiroshi [2 ]
Kai, Masahiro [2 ]
Tokino, Takashi [3 ]
Masumori, Naoya [1 ]
Suzuki, Hiromu [2 ]
机构：
[1] Sapporo Med Univ, Sch Med, Dept Urol, Sapporo, Hokkaido, Japan
[2] Sapporo Med Univ, Sch Med, Dept Mol Biol, Sapporo, Hokkaido, Japan
[3] Sapporo Med Univ, Res Inst Front Med, Med Genome Sci, Sapporo, Hokkaido, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Bladder cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-3039
引用
收藏
页码：894 / 894
页数：1
相关论文
共 50 条
  • [31] Muscle Invasive Bladder Cancer: A new Therapeutic Strategy in Cisplatin Resistance
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2018, 49 (06) : 470 - 470
  • [32] FOXO1 inactivation induces cisplatin resistance in bladder cancer
    Ide, Hiroki
    Goto, Takuro
    Teramoto, Yuki
    Mizushima, Taichi
    Jiang, Guiyang
    Nagata, Yujiro
    Inoue, Satoshi
    Baras, Alexander S.
    Kashiwagi, Eiji
    Miyamoto, Hiroshi
    CANCER SCIENCE, 2020, 111 (09) : 3397 - 3400
  • [33] The relationship between microRNAs and bladder cancer: are microRNAs useful to predict bladder cancer in suspicious patients?
    Kaba, Mehmet
    Pirincci, Necip
    Demir, Murat
    Kaba, Sultan
    Oztuzcu, Serdar
    Verep, Samed
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (10) : 2483 - 2491
  • [34] The relationship between microRNAs and bladder cancer: are microRNAs useful to predict bladder cancer in suspicious patients?
    Mehmet Kaba
    Necip Pirinççi
    Murat Demir
    Sultan Kaba
    Serdar Oztuzcu
    Samed Verep
    International Urology and Nephrology, 2023, 55 : 2483 - 2491
  • [35] Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer
    Zhang, Yi
    Wang, Zhi
    Yu, Jin
    Shi, Jia Zhong
    Wang, Chun
    Fu, Wei Hua
    Chen, Zhi Wen
    Yang, Jin
    CANCER LETTERS, 2012, 322 (01) : 70 - 77
  • [36] Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
    Ashrafizadeh, Milad
    Zarrabi, Ali
    Hushmandi, Kiavash
    Hashemi, Farid
    Moghadam, Ebrahim Rahmani
    Owrang, Marzieh
    Hashemi, Fardin
    Makvandi, Pooyan
    Goharrizi, Mohammad Ali Sheikh Beig
    Najafi, Masoud
    Khan, Haroon
    CELLULAR SIGNALLING, 2021, 78
  • [37] THE ASSOCIATION OF ABERRANT TLX3 METHYLATION WITH RESISTANCE TO CISPLATIN IN BLADDER CANCER
    Tada, Y.
    Yokomizo, A.
    Shiota, M.
    Plass, C.
    Naito, S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 225 - 225
  • [38] Targeting Metabolic Reprogramming to Overcome Gemcitabine and Cisplatin Resistance in Advanced Bladder Cancer
    Sakaguchi, Takashi
    Arima, Junya
    Yoshino, Hirofumi
    Tatarano, Syuichi
    Enokida, Hideki
    CANCER SCIENCE, 2025, 116 : 688 - 688
  • [39] The Role of c-FLIP in Cisplatin Resistance of Human Bladder Cancer Cells
    Lee, Sangchul
    Yoon, Cheol Yong
    Byun, Seok-Soo
    Lee, Eunsik
    Lee, Sang Eun
    JOURNAL OF UROLOGY, 2013, 189 (06): : 2327 - 2334
  • [40] New mechanistic insights into cisplatin resistance in muscle-invasive bladder cancer
    Feldman, Lily Elizabeth R.
    Mohapatra, Saswat
    Jones, Robert
    Tilton, Charlene
    Zuiverloon, Tahlita
    Costello, James
    Theodorescu, Dan
    CANCER RESEARCH, 2024, 84 (07)
12345